Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 877 to 926 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.002\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
203.954\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03946\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.604\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.601\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03924\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
227.596\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.017\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03917\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.018\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
244.155\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03913\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.027\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03909\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
889\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.028\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.053\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03908\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 7. [source:swissprot;acc:o15400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.012\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.028\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.055\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.585\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.037\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.491\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.323\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03902\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanine-trna synthetase. [source:refseq;acc:nm\_006567]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 13.3 kda polypeptide (ec 2.7.7.6) (rpb11). [source:swissprot;acc:p52435]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
230.811\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03888\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-phosphoinositide dependent protein kinase-1 (ec 2.7.1.37) (hpdk1). [source:swissprot;acc:o15530]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
272.878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
283.472\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
229.171\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
238.048\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03874\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin domain-containing 2; sperm-specific thioredoxin; thioredoxin domain-containing 2 (spermatozoa). [source:refseq;acc:nm\_032243]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin (atl-derived factor) (adf) (surface associated sulphydryl protein) (sasp). [source:swissprot;acc:p10599]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
237.62\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.762\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03872\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
902\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
903\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 4 (eif-3 delta) (eif3 p44) (eif-3 rna-binding subunit) (eif3 p42) (eif3g). [source:swissprot;acc:o75821]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
246.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
237.223\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03849\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
904\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 10 (eif-3 theta) (eif3 p167) (eif3 p180) (eif3 p185) (eif3a). [source:swissprot;acc:q14152]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
905\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna directed rna polymerase ii polypeptide j-related gene isoform 3; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_032959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
230.768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
906\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna directed rna polymerase ii polypeptide j-related gene isoform 1; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_145325]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
230.764\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03838\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
907\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junction plakoglobin (desmoplakin iii). [source:swissprot;acc:p14923]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
223.906\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.653\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03827\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
septin 1 (larp) (serologically defined breast cancer antigen ny-br- 24). [source:swissprot;acc:q8wyj6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
142.077\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
136.846\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03823\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uba/ubx 33.3 kda protein. [source:swissprot;acc:q04323]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.168\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.207\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03805\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 3. [source:swissprot;acc:q9unx4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.896\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03803\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prip-interacting protein pipmt; prip-interacting protein with methyltransferase domain. [source:refseq;acc:nm\_024831]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
210.863\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03801\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pdz/coiled-coil domain binding partner for the rho-family gtpase tc10; fused in glioblastoma; golgi associated pdz and coiled-coil motif containing protein; cftr-associated ligand. [source:refseq;acc:nm\_020399]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trna (5-methylaminomethyl-2-thiouridylate)-methyltransferase (ec 2.1.1.61). [source:swissprot;acc:o75648]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
146.036\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
140.692\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxyacid oxidase 2 (ec 1.1.3.15) (haox2) ((s)-2-hydroxy-acid oxidase, peroxisomal) (long chain alpha-hydroxy acid oxidase) (long- chain l-2-hydroxy acid oxidase). [source:swissprot;acc:q9nyq3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.512\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03774\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
parafibromin. [source:refseq;acc:nm\_024529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.704\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.991\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03772\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
918\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.952\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03731\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
919\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
midasin (midas-containing protein). [source:swissprot;acc:q9nu22]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
237.218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03725\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
920\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deformed epidermal autoregulatory factor 1 homolog (nuclear deaf-1 related transcriptional regulator) (nudr) (suppressin) (zinc finger mynd domain containing protein 5). [source:swissprot;acc:o75398]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
236.741\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
245.547\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0372\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rio kinase 1 isoform 1; ad034 protein. [source:refseq;acc:nm\_031480]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
922\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 1. [source:refseq;acc:nm\_018650]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
923\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 2 isoform b; elkl motif kinase 1; elkl motif kinase. [source:refseq;acc:nm\_004954]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
924\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
meiotic recombination protein spo11. [source:swissprot;acc:q9y5k1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pef protein with a long n-terminal hydrophobic domain (peflin). [source:refseq;acc:nm\_012392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.665\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.942\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03714\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.942\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03713\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/